Fibroblast heterogeneity: implications for human disease. (2018)

First Author: Lynch MD
Attributed to:  Overcoming immunological barriers to regenerative medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci93555

PubMed Identifier: 29293096

Publication URI: http://europepmc.org/abstract/MED/29293096

Type: Journal Article/Review

Volume: 128

Parent Publication: The Journal of clinical investigation

Issue: 1

ISSN: 0021-9738